IRIDEX Stock

IRIDEX Net Income

The Net Income of IRIDEX (IRIX) as of Mar 18, 2026.

Net Income

0USD

Last updated: Mar 18, 2026

In 2026, IRIDEX's profit amounted to 0 USD, a % increase from the 0 USD profit recorded in the previous year.

The IRIDEX Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

NET INCOME (M USD)
Date
NET INCOME (M USD)
Jan 1, 2005
1.67 base
Jan 1, 2006
-5.75 base
Jan 1, 2007
-22.27 base
Jan 1, 2008
-7.37 base
Jan 1, 2009
2.59 base
Jan 1, 2010
3.05 base
Jan 1, 2011
2.61 base
Jan 1, 2012
1.44 base
Jan 1, 2013
2.23 base
Jan 1, 2014
10.04 base
Jan 1, 2015
0.47 base
Jan 1, 2016
-11.71 base
Jan 1, 2017
-12.87 base
Jan 1, 2018
-12.81 base
Jan 1, 2019
-8.81 base
YEARNET INCOME (M USD)
2028 est 1.75
2027 est 0.88
2026 est -1.23
2025 est -4.73
2024 -8.91
2023 -9.57
2022 -7.55
2021 -5.23
2020 -6.33
2019 -8.81
2018 -12.81
2017 -12.87
2016 -11.71
2015 0.47
2014 10.04
2013 2.23
2012 1.44
2011 2.61
2010 3.05
2009 2.59
2008 -7.37
2007 -22.27
2006 -5.75
2005 1.67

IRIDEX Revenue

IRIDEX Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2005
37.03 M USD
1.81 M USD
1.67 M USD
Jan 1, 2006
35.9 M USD
-4.77 M USD
-5.75 M USD
Jan 1, 2007
55.53 M USD
-9.43 M USD
-22.27 M USD
Jan 1, 2008
48.53 M USD
-2.18 M USD
-7.37 M USD
Jan 1, 2009
31.03 M USD
1.23 M USD
2.59 M USD
Jan 1, 2010
32.31 M USD
1.19 M USD
3.05 M USD
Jan 1, 2011
33.16 M USD
660,000 USD
2.61 M USD
Jan 1, 2012
33.86 M USD
-860,000 USD
1.44 M USD
Jan 1, 2013
38.27 M USD
2.16 M USD
2.23 M USD
Jan 1, 2014
42.81 M USD
2.59 M USD
10.04 M USD
Jan 1, 2015
41.76 M USD
290,000 USD
470,000 USD
Jan 1, 2016
46.16 M USD
-2.45 M USD
-11.71 M USD
Jan 1, 2017
41.59 M USD
-13.03 M USD
-12.87 M USD
Jan 1, 2018
42.6 M USD
-12.87 M USD
-12.81 M USD
Jan 1, 2019
43.45 M USD
-8.97 M USD
-8.81 M USD

IRIDEX Margins

IRIDEX stock margins

The IRIDEX margin analysis displays the gross margin, EBIT margin, as well as the profit margin of IRIDEX. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for IRIDEX.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2005
49.1 %
4.89 %
4.51 %
Jan 1, 2006
52.4 %
-13.29 %
-16.02 %
Jan 1, 2007
43.72 %
-16.98 %
-40.1 %
Jan 1, 2008
40.55 %
-4.49 %
-15.19 %
Jan 1, 2009
49.76 %
3.96 %
8.35 %
Jan 1, 2010
50.14 %
3.68 %
9.44 %
Jan 1, 2011
49.13 %
1.99 %
7.87 %
Jan 1, 2012
48.29 %
-2.54 %
4.25 %
Jan 1, 2013
48.58 %
5.64 %
5.83 %
Jan 1, 2014
50.01 %
6.05 %
23.45 %
Jan 1, 2015
47.77 %
0.69 %
1.13 %
Jan 1, 2016
45.15 %
-5.31 %
-25.37 %
Jan 1, 2017
37.27 %
-31.33 %
-30.94 %
Jan 1, 2018
41.01 %
-30.21 %
-30.07 %
Jan 1, 2019
41.29 %
-20.64 %
-20.28 %

IRIDEX Stock analysis

What does IRIDEX do? IRIDEX Corp is a global medical technology company that specializes in the development, manufacturing, marketing, and distribution of innovative laser-based medical devices and services. The company was originally founded in 1989 and is headquartered in Mountain View, California. IRIDEX's business model is divided into various divisions, each serving different markets. The divisions include ophthalmology, otolaryngology (ENT), gynecology and urology, as well as scientific research. The company offers a wide range of high-tech laser systems that can be used to treat various conditions, such as retinal diseases, glaucoma, nasal and throat disorders, gynecological and urological conditions, and other medical applications. One of the most well-known divisions of IRIDEX is ophthalmology, which offers a wide range of laser systems for the treatment of retinal diseases. These retinal diseases include diabetic retinopathy, retinal edema, age-related macular degeneration, and retinal detachment. The company also has a high-tech system called Cyclo G6TM, which is used for the treatment of glaucoma. This system can also be used in conjunction with other devices, such as ultrasound systems, for optimized clinical effectiveness. The ENT division offers laser systems for the treatment of nasal and throat disorders, such as snoring, polyps, stenosis, and tumors. The range of laser systems varies from simple systems to advanced systems that can be connected to a flexible endoscope for more precise treatment. IRIDEX's gynecology and urology division offers laser systems for various applications, such as urinary incontinence, bladder problems, tumor removal, prostate tissue removal, and medical treatments to improve sexual function. Laser systems can also be used in combination with other medical devices, such as ultrasound systems. The company places great emphasis on scientific research and development to create and introduce innovative technologies to the market. Therefore, IRIDEX collaborates closely with various research institutes, universities, and medical professionals to further develop its technological advances. The company is also committed to providing comprehensive training and support to its customers to ensure that they use the devices safely and effectively. Overall, IRIDEX Corp has established itself as an innovative and powerful multinational company in the field of medical technology. The company is constantly striving to expand its range of products and services and impress its customers with its high-quality solutions. IRIDEX is confident that it will continue to play a significant role in the medical technology industry in the future. IRIDEX is one of the most popular companies on Eulerpool.com.

Net Income Details

Understanding IRIDEX's Profit Margins

The profit margins of IRIDEX represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of IRIDEX's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating IRIDEX's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

IRIDEX's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When IRIDEX’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about IRIDEX stock

On Eulerpool you can find the complete historical development of The Net Income IRIDEX since 2006 – with annual values, charts, and detailed analysis.

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Income Statement — IRIDEX

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

All Key Metrics — IRIDEX